Ionis closes $770M 0% convertible notes offering, repurchases $200M of 2026 notes

IONIS PHARMACEUTICALS INC

Issued $770M aggregate principal of 0.00% Convertible Senior Notes due 2030 (including full greenshoe), net proceeds ~$751.2M.
Used ~$267.6M of net proceeds to repurchase $200M of existing 2026 convertible notes via concurrent transactions.
Remaining proceeds for further repurchases of 2026 notes and general corporate purposes.
Initial conversion rate: 10.1932 shares/$1,000, conversion price ~$98.10 (35% premium over Nov 12 close of $72.67).
Notes mature Dec 1, 2030, no regular interest, redeemable after Dec 6, 2028 if stock ≥130% of conversion price.

item 1.01item 2.03item 3.02item 8.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.